Predict your next investment

Intezyne Technologies company logo
Corporation
HEALTHCARE | Drug Development
intezyne.com

See what CB Insights has to offer

Total Raised

$19.32M

Investors Count

1

Deal Terms

1

Intezyne Technologies Funding, Intezyne Technologies Valuation & Intezyne Technologies Revenue

3 Fundings

Intezyne Technologies's latest funding round was a Series A for $10M on October 6, 2017.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/6/2017

Series A

$10M

$0.00B

((9.99x))

FY 1234

4

6/9/2016

Unattributed - II

$99M

$0.00B

((9.99x))

FY 1234

10

6/25/2013

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

Date

10/6/2017

6/9/2016

6/25/2013

Round

Series A

Unattributed - II

Unattributed

Amount

$10M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

4

10

10

Intezyne Technologies Deal Terms

1 Deal Term

Intezyne Technologies's deal structure is available for 1 funding round, including their Series A from October 06, 2017.

Round

Series A

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

Intezyne Technologies Investors

1 Investors

Intezyne Technologies has 1 investors. Gaston Capital invested in Intezyne Technologies's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/6/2017

10/6/2017

1
Series A

David Robb, and Glenn Walthall

Private Equity

North Carolina

First funding

10/6/2017

Last Funding

10/6/2017

Investor

Rounds

1
Series A

Board Seats

David Robb, and Glenn Walthall

Type

Private Equity

Location

North Carolina

Intezyne Technologies Acquisitions

1 Acquisition

Intezyne Technologies acquired 1 company. Their latest acquisition was Niiki Pharma on June 19, 2013.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/19/2013

Debt

$1.25M

Acquired

1

Date

6/19/2013

Investment Stage

Debt

Companies

Valuation

Total Funding

$1.25M

Note

Acquired

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.